Skip to main content
NIH funding notice RFA-DK-18-504

Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)

Closed on November 21, 2018.

Posted
August 30, 2018
Close date
November 21, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,518,309 in first-year total cost, median $1,518,309.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-3 (M2)]1

Most frequent institutions

  1. UNIVERSITY OF MICHIGAN AT ANN ARBOR1
Competing awards under RFA-DK-18-504 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019CureGN2U24DK100845-07GILLESPIE, BRENDA WGIPSON, DEBBIE SKRETZLER, MATTHIASROBINSON, BRUCE MARSHALLUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$1,518,309ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DK-18-504: Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed) | ScienceDex | ConductScience